Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study.

MLA

Xu, Jianming, et al. “Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 36, no. 4, Feb. 2018, pp. 350–58. EBSCOhost, https://doi.org/10.1200/JCO.2017.74.3245.

APA

Xu, J., Kim, T. W., Shen, L., Sriuranpong, V., Pan, H., Xu, R., Guo, W., Han, S.-W., Liu, T., Park, Y. S., Shi, C., Bai, Y., Bi, F., Ahn, J. B., Qin, S., Li, Q., Wu, C., Ma, D., Lin, D., & Li, J. (2018). Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(4), 350–358. https://doi.org/10.1200/JCO.2017.74.3245

Chicago

Xu, Jianming, Tae Won Kim, Lin Shen, Virote Sriuranpong, Hongming Pan, Ruihua Xu, Weijian Guo, et al. 2018. “Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 36 (4): 350–58. doi:10.1200/JCO.2017.74.3245.